| INNOCAN PHARMA CORP. |
| Kanada |
| Gesundheit |
| CA45783P5085 / A41FTP |
| IP40 (Frankfurt) |
| FRA:IP40, ETR:IP40, IP40:GR |
| - |
| https://innocanpharma.com.. |
|
InnoCan Pharma Corporation is a pharmaceutical technology company founded in 2018 and headquartered in Calgary, Canada. It specializes in innovative drug delivery platforms that combine cannabidiol (C..
>Volltext.. |
| 18.63 Mio. EUR |
| 16.02 Mio. EUR |
| 23.79 Mio. EUR |
| -1.05 Mio. EUR |
| -2.83 Mio. EUR |
| -0.63 EUR |
| 1.33 Mio. EUR |
| 6.42 Mio. EUR |
| 0.5 Mio. EUR |
| 2.48 |
| -11.43% |
| -17.66% |
| - |
| - |
| - |
| - |
| INNOCAN |
| 14.03.26 |
|